Stock overview
Newamsterdam Pharma Company
Explore the company, reported ownership, price history, and available source evidence.
NEWAMSTERDAM PHARMA COMPANY (NAMS) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $19.74
- · NAMS
- Tracked holders
- 3 funds
- Latest available 13F per fund
NAMS · USD
Price
Close · Nov 18, 2026
- Range low
- $18.89
- Range high
- $41.45
- Observations
- 252
- Session date
- Nov 18, 2026
Nov 18, 2025–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Duquesne Family Office largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | +9% 26'Q3 | $81,646,000 | 1.83% |
| Viking Global Investors position history Q3 2026 · filed Nov 16, 2026 · SEC filing | −41% 26'Q3 | $59,922,316 | 0.18% |
| Tudor Investment Corp position history Q3 2026 · filed Nov 16, 2026 · SEC filing | +7% 26'Q3 | $2,067,370 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market